首页|硫酸镁联合拉贝洛尔治疗妊娠期高血压的临床效果及可行性分析

硫酸镁联合拉贝洛尔治疗妊娠期高血压的临床效果及可行性分析

扫码查看
目的 探讨硫酸镁联合拉贝洛尔在妊娠期高血压患者中的临床疗效,并分析其可行性。方法 64 例妊娠期高血压患者,采用随机数字表法分为对照组(32 例)和观察组(32 例)。对照组患者实施单药硫酸镁治疗,观察组患者实施硫酸镁联合拉贝洛尔治疗。比较两组患者的临床疗效,血压和心率,24 h尿蛋白定量和微量白蛋白水平,不良母婴结局发生率。结果 与对照组(81。3%)比较,观察组患者的临床总有效率(96。9%)明显升高(P<0。05)。与治疗前比较,两组患者治疗后的心率、收缩压和舒张压均有所降低(P<0。05);与对照组比较,观察组患者治疗后的心率、收缩压和舒张压明显更低(P<0。05)。与治疗前比较,两组患者治疗后的 24 h尿蛋白定量和微量白蛋白水平均有所降低(P<0。05);与对照组比较,观察组患者治疗后的 24 h尿蛋白定量和微量白蛋白水平明显更低(P<0。05)。对照组发生 1 例产后出血和 1 例胎儿窘迫,观察组仅发生 1 例产后出血;与对照组(6。3%)比较,观察组的不良母婴结局发生率(3。1%)更低,但无明显差异(P>0。05)。结论 硫酸镁联合拉贝洛尔在妊娠期高血压患者中的临床疗效显著,能有效改善患者的临床症状,恢复血压和心率,降低 24 h尿蛋白定量和微量白蛋白水平,有利于母婴结局,值得临床推广应用。
Analysis of clinical effect and feasibility of magnesium sulfate combined with labetalol in the treatment of pregnancy induced hypertension
Objective To explore the clinical efficacy of magnesium sulfate combined with labetalol in the treatment of pregnancy induced hypertension,and analyze its feasibility.Methods 64 patients with pregnancy induced hypertension were divided into a control group(32 cases)and an observation group(32 cases)by random number table method.The control group was treated with magnesium sulfate alone,and the observation group was treated with magnesium sulfate combined with labetalol.Comparison was made on clinical efficacy,blood pressure,heart rate,24 h urinary protein quantification and microalbumin levels,and the incidence of adverse maternal and infant outcomes between the two groups.Results Compared with the control group(81.3%),the total clinical effective rate of the observation group(96.9%)was significantly increased(P<0.05).Compared with before treatment,the heart rate,systolic blood pressure and diastolic blood pressure in both groups decreased after treatment(P<0.05).Compared with the control group,the heart rate,systolic blood pressure and diastolic blood pressure in the observation group were significantly lower after treatment(P<0.05).Compared with before treatment,the 24 h urinary protein quantification and microalbumin levels in both groups decreased after treatment(P<0.05).Compared with control group,the 24 h urinary protein quantification and microalbumin levels in the observation group were significantly lower after treatment(P<0.05).There was 1 case of postpartum hemorrhage and 1 case of fetal distress in the control group,and only 1 case of postpartum hemorrhage in the observation group.Compared with the control group(6.3%),the incidence of adverse maternal and infant outcomes in the observation group(3.1%)was lower,but there was no significant difference(P>0.05).Conclusion Magnesium sulfate combined with labetalol has significant clinical efficacy in patients with pregnancy induced hypertension,which can effectively improve clinical symptoms of patients,restore blood pressure and heart rate,reduce 24 h urinary protein quantification and microalbumin levels,which is conducive to maternal and infant outcomes,and is worthy of clinical promotion and application.

Pregnancy induced hypertensionMagnesium sulfateLabetalol

廖飞娥

展开 >

362400 福建省泉州市安溪县医院产科

妊娠期高血压 硫酸镁 拉贝洛尔

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(9)